Your browser doesn't support javascript.
loading
Allergy immunotherapy across the life cycle to promote active and healthy ageing: from research to policies: An AIRWAYS Integrated Care Pathways (ICPs) programme item (Action Plan B3 of the European Innovation Partnership on active and healthy ageing) and the Global Alliance against Chronic Respiratory Diseases (GARD), a World Health Organization GARD research demonstration project.
Calderon, M A; Demoly, P; Casale, T; Akdis, C A; Bachert, C; Bewick, M; Bilò, B M; Bohle, B; Bonini, S; Bush, A; Caimmi, D P; Canonica, G W; Cardona, V; Chiriac, A M; Cox, L; Custovic, A; De Blay, F; Devillier, P; Didier, A; Di Lorenzo, G; Du Toit, G; Durham, S R; Eng, P; Fiocchi, A; Fox, A T; van Wijk, R Gerth; Gomez, R M; Haathela, T; Halken, S; Hellings, P W; Jacobsen, L; Just, J; Tanno, L K; Kleine-Tebbe, J; Klimek, L; Knol, E F; Kuna, P; Larenas-Linnemann, D E; Linneberg, A; Matricardi, M; Malling, H J; Moesges, R; Mullol, J; Muraro, A; Papadopoulos, N; Passalacqua, G; Pastorello, E; Pfaar, O; Price, D; Del Rio, P Rodriguez.
Afiliación
  • Calderon MA; National Heart and Lung Institute, Royal Brompton Hospital NHS, Imperial College London, London, UK.
  • Demoly P; Unité d'allergologie, Département de Pneumologie et AddictologieHôpital Arnaud de Villeneuve, CHRU de Montpellier, Sorbonne Universités, UPMC Paris 06, UMR-S 1136, IPLESP, Equipe EPAR, 75013 Paris, France.
  • Casale T; University of South Florida Morsani College of Medicine, Tampa, FL USA.
  • Akdis CA; Christine Kühne Center for Allergy Research and Education (CK-CARE), Swiss Institute of Allergy and Asthma Research (SIAF)University of Zurich, Davos, Switzerland.
  • Bachert C; Upper Airways Research Laboratory (URL), ENT Department, University Hospital Ghent, Ghent, Belgium.
  • Bewick M; iQ4U consultants Ltd, London, UK.
  • Bilò BM; Allergy Unit, Department of Internal Medicine, University Hosp Ospedali Riuniti, Ancona, Italy.
  • Bohle B; Department of Pathophysiology and Allergy Research, Center of Pathophysiology, Infectiology and Immunology, Medical University of Vienna, Vienna, Austria.
  • Bonini S; Second University of Naples and IFT-CNR, Rome, Italy.
  • Bush A; National Heart and Lung Institute, Royal Brompton Hospital NHS, Imperial College London, London, UK.
  • Caimmi DP; Unité d'allergologie, Département de Pneumologie et AddictologieHôpital Arnaud de Villeneuve, CHRU de Montpellier, Sorbonne Universités, UPMC Paris 06, UMR-S 1136, IPLESP, Equipe EPAR, 75013 Paris, France.
  • Canonica GW; Allergy and Respiratory Diseases Clinic, DIMI, University of Genoa, IRCCS AOU San Martino-IST, Genoa, Italy.
  • Cardona V; Allergy Section, Department of Internal Medicine, Hospital Universitari Vall d'Hebron, Barcelona, Spain.
  • Chiriac AM; Division of Allergy, Hôpital Arnaud de Villeneuve, Department of Pulmonology, University Hospital of Montpellier, Montpellier - UPMC Univ Paris 06, UMRS 1136, Equipe - EPAR - IPLESP, Sorbonne Universités, Paris, France.
  • Cox L; Nova Southeastern University, Ft. Lauderdale, FL USA.
  • Custovic A; National Heart and Lung Institute, Royal Brompton Hospital NHS, Imperial College London, London, UK.
  • De Blay F; Allergy Division, Chest Disease Department, University Hospital of Strasbourg, Strasbourg, France.
  • Devillier P; University Versailles Saint-Quentin and Clinical Pharmacology Unit, UPRES EA 220, Department of Airway Diseases, Foch Hospital, Suresnes, France.
  • Didier A; Respiratory Diseases Department, Rangueil-Larrey Hospital, Toulouse, France.
  • Di Lorenzo G; Dipartimento BioMedico di Medicina Interna e Specialistica (Di.Bi.M.I.S), University of Palermo, Palermo, Italy.
  • Du Toit G; Guy's and St. Thomas' NHS Trust, Kings College, London, UK.
  • Durham SR; Allergy and Clinical Immunology Section, National Heart and Lung Institute, Imperial College London, London, UK.
  • Eng P; Department of Pediatric Pulmonology and Allergy, Children's Hospital, Aarau, Switzerland.
  • Fiocchi A; Division of Allergy, Department of Pediatrics, Bambino Gesù Pediatric Hospital, Vatican City, Rome, Italy.
  • Fox AT; King's College London Allergy Academy, London, UK.
  • van Wijk RG; Section of Allergology, Department of Internal Medicine, Erasmus Medical Center, Building Rochussenstraat, Rotterdam, The Netherlands.
  • Gomez RM; Unidad Alergia and Asma, Hospital San Bernardo, Salta, Argentina.
  • Haathela T; Skin and Allergy Hospital, Helsinki University Hospital, Helsinki, Finland.
  • Halken S; Hans Christian Andersen Children's Hospital, Odense University Hospital, Odense, Denmark.
  • Hellings PW; Clinical Department of Otorhinolaryngology, Head and Neck Surgery, University Hospitals Leuven, KU Leuven, Louvain, Belgium.
  • Jacobsen L; Allergy Learning and Consulting, Secretary Immunotherapy Interest Group EAACI, Copenhagen, Denmark.
  • Just J; Allergology Department, Centre de l'Asthme et des Allergies, Hôpital d'Enfants Armand-Trousseau, INSERM, UMR_S 1136, Sorbonne Universités, UPMC Univ Paris, Institut Pierre Louis d'Epidémiologie et de Santé Publique, Equipe EPAR, Paris, France.
  • Tanno LK; Hospital Sírio Libanês, São Paulo, Brazil ; University Hospital of Montpellier, Montpellier, France ; UPMC Paris 06, UMR-S 1136, IPLESP, Equipe EPAR, Sorbonne Universités, Paris, France.
  • Kleine-Tebbe J; Allergy and Asthma Center Westend, Outpatient Clinic and Clinical Research Center, Ackermann, Hanf, & Kleine-Tebbe, Berlin, Germany.
  • Klimek L; Center for Rhinology and Allergology, German Society for Otorhinolaryngology HNS, Wiesbaden, Germany.
  • Knol EF; Departments of Immunology and Dermatology/Allergology, University Medical Center Utrecht, Heidelberglaan, Utrecht, The Netherlands.
  • Kuna P; Medical University of Lodz, Lodz, Poland.
  • Larenas-Linnemann DE; ARIA, Mexico, DF Mexico ; AAAAI, Hospital Médica Sur, Mexico, DF Mexico.
  • Linneberg A; Research Centre for Prevention and Health, The Capital Region of Denmark, Copenhagen, Denmark ; Department of Clinical Experimental Research, Rigshospitalet, Copenhagen, Denmark ; Department of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.
  • Matricardi M; Pediatric Pneumology and Immunology, Charité Medical University, Berlin, Germany.
  • Malling HJ; Danish Allergy Centre, Allergy Clinic, Gentofte University Hospital, Hellerup, Denmark.
  • Moesges R; IMSIE, Klinikum der Universität zu Köln A. ö. R., Cologne, Germany.
  • Mullol J; Unitat de Rinologia i Clínica de l'Olfacte, ENT Department, Hospital Clínic, Clinical and Experimental Respiratory Immunoallergy, IDIBAPS, CIBERES, Barcelona, Catalonia Spain.
  • Muraro A; Department of Women and Child Health, Food Allergy Referral Centre Veneto Region, Padua General University Hospital, Padua, Italy.
  • Papadopoulos N; Allergy Unit, 2nd Pediatric Clinic, University of Athens, Athens, Greece.
  • Passalacqua G; Allergy and Respiratory Diseases, IRCCS San Martino-IST, Univesity of Genoa, Genoa, Italy.
  • Pastorello E; ASST Grande Ospedale Metropolitano Niguarda, P.zza Ospedale Maggiore, Milan, Italy.
  • Pfaar O; Department of Otorhinolaryngology, Head and Neck Surgery, Universitätsmedizin Mannheim, Mannheim, Germany ; Medical Faculty Mannheim, Heidelberg University, Heidelberg, Germany ; Center for Rhinology and Allergology, Wiesbaden, Germany.
  • Price D; Division of Applied Health Sciences, Primary Care Respiratory Medicine, Academic Primary Care, University of Aberdeen, Aberdeen, Scotland, UK ; Research in Real Life (RiRL), Oakington, Cambridge, UK ; Optimum Patient Care Ltd, Singapore, Singapore.
  • Del Rio PR; Allergy Section, Hospital Infantil Universitario Niño Jesús, Madrid, Spain.
Clin Transl Allergy ; 6: 41, 2016.
Article en En | MEDLINE | ID: mdl-27895895
Allergic diseases often occur early in life and persist throughout life. This life-course perspective should be considered in allergen immunotherapy. In particular it is essential to understand whether this al treatment may be used in old age adults. The current paper was developed by a working group of AIRWAYS integrated care pathways for airways diseases, the model of chronic respiratory diseases of the European Innovation Partnership on active and healthy ageing (DG CONNECT and DG Santé). It considered (1) the political background, (2) the rationale for allergen immunotherapy across the life cycle, (3) the unmet needs for the treatment, in particular in preschool children and old age adults, (4) the strategic framework and the practical approach to synergize current initiatives in allergen immunotherapy, its mechanisms and the concept of active and healthy ageing.
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Tipo de estudio: Guideline Idioma: En Revista: Clin Transl Allergy Año: 2016 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Tipo de estudio: Guideline Idioma: En Revista: Clin Transl Allergy Año: 2016 Tipo del documento: Article